Global bioabsorbable stents market to hit USD 253.9M

The global bioabsorbable stents market is on track for remarkable growth over the next decade, with market value expected to leap from USD 171.8 million in 2023 to an impressive USD 253.9 million by 2033. This substantial increase is forecasted to be driven by a steady Compound Annual Growth Rate (CAGR) of 4% in global bioabsorbable stents sales.

A significant factor contributing to this growth is the rising demand for bioabsorbable stents, particularly for the treatment of diseases affecting blood vessels and the heart, which are prevalent among elderly and middle-aged patients. As the global demographic structure shifts towards an aging population, the need for advanced and effective treatments is becoming more critical, creating a robust market for bioabsorbable stents.

The bioabsorbable stents market is benefiting from the increasing prevalence of cardiovascular diseases and related health conditions, which necessitate innovative and less invasive treatment options. Bioabsorbable stents, known for their ability to naturally dissolve in the body after fulfilling their purpose, offer a promising alternative to traditional metal stents, thus driving their adoption in medical practices worldwide.

With the healthcare sector continually evolving and the growing emphasis on improving patient outcomes, the prospects for bioabsorbable stents appear extremely promising. As the market expands, stakeholders can expect enhanced research and development efforts, leading to further advancements in bioabsorbable stent technologies.

“Market players can expand their share in China for bioabsorbable stents, due to significant opportunities present in this market. However, they must take into account the preference for value products as the government is forcing a decrease in the overall product prices. Additionally, they must look out for the long-term viability of the product,” says an FMI analyst. Future Market Insights